Vascor (Imidapril)

Quick links

Choose a section

Quick links to important sections

Advertisements

Vascor (Imidapril)

Advertisements
Advertisements

Method of action: Antihypertensive

Treatment option:

Advertisements

Overview of Vascor (Imidapril)

Property Description
Active ingredient Imidapril Hydrochloride
Form Oral Tablet
Pharmacological class Angiotensin-Converting Enzyme (ACE) Inhibitor
Common use Management of high blood pressure (Antihypertensive)
Origin Synthetic Compound

The medicinal entity Imidapril (often recognized by the trade name Vascor) is a highly specific, synthetic antihypertensive agent primarily used to regulate systemic arterial pressure. It is provided in the high-level dosage form of an oral tablet and functions as a powerful Angiotensin-Converting Enzyme (ACE) Inhibitor, acting systemically via oral administration.


What Type of Medicine is Imidapril?

Imidapril belongs to the Angiotensin-Converting Enzyme (ACE) Inhibitor pharmacological class, a class widely recognized for its efficacy in cardiovascular medicine. Its primary active ingredient is Imidapril Hydrochloride. This substance is uniquely classified as an ester prodrug, meaning the administered compound is biologically inactive until the liver converts it into its fully therapeutic form, the active metabolite Imidaprilat. This particular metabolic feature is clinically recognized for providing a sustained duration of action, distinguishing its profile from some older ACE inhibitors. As a single-ingredient cardiovascular agent, Imidapril is the active therapeutic component, available by prescription only.


General Purpose and Physiological Action

The general purpose of Imidapril is to effectively manage and decrease chronic high blood pressure (hypertension). This function is achieved by inducing widespread vasodilation across the body's arterial network. This physiological action—relaxing and widening the blood vessels—leads to a measurable reduction in peripheral vascular resistance. This foundational therapeutic benefit directly addresses the core mechanical issue of hypertension, making it a critical choice in managing persistent elevated pressure, and ultimately helping reduce the overall workload placed on the heart muscle.

Advertisements

What side effects are possible with Vascor (Imidapril)?

Possible side effects and safety information

The safety profile of Imidapril Hydrochloride, an Angiotensin-Converting Enzyme (ACE) inhibitor, is established through official regulatory documentation that classifies adverse reactions by frequency and physiological system.

Frequency-Classified Adverse Reactions

Official documents classify potential effects based on their statistical occurrence rate:

  • Commonly Reported: These include persistent dry cough, headache, dizziness, lightheadedness, and symptomatic hypotension (low blood pressure).
  • Rarely Reported: Less frequent events, though officially documented, include significant electrolyte disturbances such as hyperkalemia (elevated potassium), and specific skin reactions.

Systemic Safety Scope

Adverse reactions are grouped by the physiological system they affect, as defined in regulatory labeling:

System-Organ Class Example Adverse Effects (Regulatory Classification)
Respiratory Dry cough
Nervous System Headache, Dizziness, Confusion
Vascular Hypotension, Palpitations
Gastrointestinal Nausea, Vomiting, Diarrhea
Renal/Urinary Renal impairment, Acute renal failure

Serious Adverse Reactions and Restrictions

Official labeling documents highlight rare but clinically significant adverse reactions, including Angioedema (severe swelling of the face, tongue, and throat) and Acute Renal Failure. The medicine is contraindicated in patients with a history of Angioedema related to a previous ACE inhibitor and during the second and third trimesters of pregnancy due to risk of fetal injury. Dizziness and hypotension are officially noted as being more likely to occur following the initial dose or when the dosage is increased.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The information below is based strictly on the official regulatory documentation for Imidapril and details the documented manifestations of overdose and the required emergency actions.


Documented Overdose Manifestations

The most commonly documented clinical sign of an Imidapril overdose is Hypotension (severely low blood pressure), which is an exaggerated extension of the medicine’s primary therapeutic effect. In severe cases, this pronounced drop in blood pressure can lead to life-threatening complications.

Classification Manifestation/Outcome
Principal Manifestation Profound Hypotension
Severe Outcome Risk Circulatory Shock
Associated Class Risks Acute Renal Failure and Hyperkalaemia

Required Emergency Actions

Immediate medical attention or contacting emergency services is mandated at the first suspicion of an Imidapril overdose, regardless of whether symptoms are present. All symptomatic or hypotensive patients require hospital observation and continuous monitoring for a minimum of 4 to 24 hours until vital signs stabilize, as stipulated in official prescribing information.

Treatment Approach Regulatory Guidance
Antidote Status No specific antidote is documented
Primary Treatment Symptomatic and Supportive Care
Supportive Measure Intravenous fluid infusion (for hypotension)

The management is focused on stabilizing the cardiovascular system due to the absence of a specific reversal agent.

Advertisements

Therapeutic Uses of Vascor (Imidapril)

What Vascor (Imidapril) Treats: Main Uses and Benefits

Imidapril is a medication that is commonly used to help manage chronic cardiovascular and renal conditions. Its therapeutic domains are associated with Systemic Cardiovascular Regulation and Cardioprotection. This medication is applied in clinical settings marked by chronic conditions such as Essential Hypertension, Chronic Heart Failure, and Diabetic Nephropathy.

The medication is commonly used to help with lowering systemic arterial pressure, managing symptoms related to reduced cardiac pumping efficiency, and addressing patterns of kidney stress like proteinuria. In clinical settings, Imidapril is often used during phases when supportive symptom management is appropriate.

“This therapy assists with maintaining functional stability and supports patients during episodes of heightened discomfort related to systemic vascular strain.”

It is commonly used to provide symptomatic support in situations involving persistent elevated pressure and may assist with reducing the risk of future cardiovascular events. For patients with heart failure, it may support an improvement in physical working capacity and exercise tolerance during daily activities.


Quick Fact: Supportive Management of Elevated Pressure

Imidapril is typically relevant in contexts involving heightened systemic burden, where supportive relief may assist with managing blood pressure and easing the overall symptom load on the heart.

Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Vascor (Imidapril) — Official Regulatory Information

The eligibility for Vascor (Imidapril) is defined by strict regulatory criteria based on age, physiological status, and specific medical history. Use is primarily approved for Adults with conditions such as essential hypertension. The Pediatric Population is generally not recommended as safety and efficacy have not been established.


Absolute Contraindications (Must Not Use)

Condition / Population Status
History of Angioedema Contraindicated (Includes hereditary, idiopathic, or prior ACE inhibitor-related)
Pregnancy and Lactation Contraindicated (Prohibited in all stages of pregnancy)
Hypersensitivity to any ACE Inhibitor Contraindicated
Severe Renal Impairment Contraindicated (Creatinine Clearance < 30 mL/min)

Conditional Use (Restrictions Apply)

Use is restricted for specific populations, requiring special consideration from a healthcare professional, as outlined in official labeling:

  • Elderly Patients (65+): Eligible, but typically require a lower initial starting condition.
  • Moderate Renal or Hepatic Impairment: Eligible only under conditional use and careful regulatory monitoring.
  • Renal Artery Stenosis: Eligible only under strict supervision due to risk of hypotension.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information regarding Vascor (Imidapril) interactions primarily concerns additive pharmacological effects and electrolyte management, especially regarding the renin-angiotensin-aldosterone system (RAAS).

Contraindicated and Restricted Combinations

Classification Interacting Substance/Class
Contraindicated Aliskiren in patients with diabetes or moderate-to-severe renal impairment
Restricted Angiotensin II Receptor Blockers (ARBs), forming dual RAAS blockade

Clinically Significant Interactions

Vascor requires caution when co-administered with substances that affect blood pressure, renal function, or serum potassium levels.

Interactions Affecting Electrolytes and Blood Pressure:

  • Potassium-Sparing Diuretics (e.g., Spironolactone) and Potassium Supplements increase the risk of hyperkalemia (high serum potassium). Monitoring of potassium levels is necessary.
  • Other Antihypertensives and Diuretics can lead to an enhanced hypotensive effect (low blood pressure).
  • Alcohol may also potentiate the blood pressure-lowering effect.

Interactions Affecting Renal Function and Efficacy:

  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) may reduce Imidapril's blood pressure-lowering effect and increase the risk of worsening renal function.
  • Lithium clearance may be reduced by Imidapril, resulting in elevated serum lithium levels and potential toxicity; frequent monitoring is required.

Administration Notes

To prevent potential decreased bioavailability, some regulatory information suggests that Antacids should be administered separated from Vascor by approximately two hours. In patients with pre-existing volume depletion or severe renal impairment, the risk of interaction-related adverse effects is heightened.

Advertisements

Mechanism of Action

Imidapril is an ester prodrug that undergoes hepatic hydrolysis to its active metabolite, imidaprilat. The primary biological target is the Angiotensin-Converting Enzyme (ACE), a zinc-dependent metallopeptidase predominantly expressed in the endothelium, especially in pulmonary tissue. Imidaprilat functions as a competitive inhibitor of ACE, occupying its active site.

Inhibition of ACE blocks the molecular pathway of converting the decapeptide Angiotensin I into the octapeptide Angiotensin II.

Downstream, the reduction of Angiotensin II diminishes its signaling through the AT1 receptor on vascular smooth muscle cells, decreasing IP3 and diacylglycerol (DAG) second messengers and subsequent intracellular calcium release. This results in vasodilation and a reduction in systemic vascular resistance.

Furthermore, reduced Angiotensin II decreases the stimulation of Aldosterone secretion from the adrenal cortex. This intracellular consequence decreases Na^+ and water reabsorption in the distal nephron, leading to natriuresis and a reduction in plasma volume. Concurrently, ACE inhibition reduces the degradation of Bradykinin, an endogenous vasodilator, increasing its local concentration and contributing to vasodilation through nitric oxide and prostacyclin release. The combined effects modulate systemic blood pressure.

Advertisements

Dosage and Administration Information

Vascor (Imidapril) is an Angiotensin-Converting Enzyme (ACE) inhibitor typically used to treat essential hypertension and, in some regions, congestive heart failure or diabetic nephropathy.

Administration Guidelines

  • Dosage: Take this medicine exactly as prescribed by your healthcare provider. Dosing is highly individualized based on your condition, age, and kidney function. Common starting doses for hypertension are 5 mg once daily, which may be adjusted to a maintenance dose of 10 mg, up to a maximum of 20 mg once daily. Elderly patients or those with kidney impairment may start at a lower dose of 2.5 mg.
  • Timing: Vascor is generally taken once a day.
  • Before Meals: The tablet should be swallowed whole with water about 15 minutes before a meal, as food can significantly decrease the absorption of imidapril.
  • First Dose: The first dose may cause temporary dizziness or lightheadedness, so it is often recommended to take the initial dose at bedtime.

Important Considerations

  • Consistency: Take your dose at approximately the same time each day to maintain consistent blood levels.
  • Missed Dose: If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and return to your regular schedule. Do not take two doses at the same time to compensate for a missed one.
  • Monitoring: Regular medical check-ups and blood tests (especially to monitor kidney function and serum potassium levels) are necessary throughout treatment. Do not discontinue Vascor without consulting your doctor, even if you feel better.
Advertisements

Recent Clinical Evidence

Vascor (Imidapril): Recent Clinical Evidence


Evidence for Use in Managing High Blood Pressure

Research has primarily examined Imidapril using Randomized Controlled Trials (RCTs). These studies were evaluated in adult populations with mild to moderate essential hypertension. Researchers monitored changes in systemic blood pressure, using measurements both in the clinic and throughout the day. Studies reported measurements of blood pressure values across the study duration compared to baseline.

Evidence for Use in Chronic Heart Failure

Research has explored the use of Imidapril in patients with conditions marked by functional limitations, such as chronic heart failure. Studies monitored measurements related to Left Ventricular Ejection Fraction (LVEF) and concentrations of neurohormone biomarkers of cardiac strain. Reported findings concerning functional outcomes are frequently discussed within the context of the effects observed with the broader ACE inhibitor pharmacological class.

Evidence for Diabetic Nephropathy (Kidney Effects)

Clinical research was observed in patient populations, primarily those with diabetes, to understand effects related to systemic imbalance in the kidneys. Studies examined renal endpoints, monitoring changes in the Urinary Albumin Excretion Rate (UAE) and total urinary protein levels. Measurements of urinary protein excretion were reported over the study intervals.

Areas of Uncertainty and Research Gaps

Long-term outcomes extending beyond one year are not well characterized by multi-year RCTs focused only on this agent. Data for certain groups remain insufficient, particularly for populations presenting with severe forms of high blood pressure or heart failure, as these groups were generally not included in the main trials. The evidence quality varies across studies, meaning that some findings are derived from observational settings rather than controlled trials.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Vascor (Imidapril) (FAQ)


Q: How quickly does Vascor start working to lower blood pressure?

Official studies and clinical data indicate that the active form of the medicine, Imidaprilat, reaches its peak concentration in the blood within approximately five to six hours after taking the tablet. This timing aligns with when the maximal reduction in blood pressure is typically observed in studies.


Q: What are the most common side effects of Vascor that people report online?

Official regulatory documents classify adverse reactions based on their statistical frequency in clinical trials. The most commonly reported effects include a persistent dry cough, headache, and dizziness or lightheadedness.


Q: What foods or drinks should I limit while taking Vascor?

Regulatory documents note that alcohol may increase the blood pressure-lowering effect of Vascor. Additionally, caution is advised regarding high intake of potassium-rich foods or the use of salt substitutes containing potassium. This is because Vascor can increase the risk of elevated potassium levels in the blood (hyperkalemia).


Q: Can I take Imidapril with common pain relievers like ibuprofen?

Official warnings state that Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), a class of medication that includes ibuprofen, may reduce the blood pressure-lowering effect of Vascor. These substances may also increase the risk of reduced kidney function when taken together.


Q: Can Vascor affect my ability to drive or operate machinery?

Due to the potential for side effects such as dizziness, lightheadedness, or drowsiness, official warnings advise caution regarding driving or operating machinery if these symptoms occur. The recommendation is to proceed with care until the individual's response to the medicine is understood.


Q: How long do side effects from Vascor usually last when starting the medicine?

Side effects such as dizziness and lightheadedness are noted to be more likely to occur after the initial dose. The active substance in the medicine typically reaches a steady concentration in the blood within approximately five days of consistent, daily dosing.


Q: Are there specific times I should avoid getting up too quickly while on Vascor?

Lightheadedness or dizziness may occur, especially after the first dose or after any dose increase. To reduce the risk of temporary lightheadedness from suddenly lowered blood pressure, caution is often suggested when rising quickly from a sitting or lying position.


Q: Can I take cold and flu medicine while on Imidapril?

Cold and flu medicines often contain ingredients such as NSAIDs (pain relievers) or sympathomimetics (decongestants). Regulatory documents describe these substances as having potential interactions with Vascor and may be noted as having potential interactions.


Q: Is Vascor typically a long-term medication?

Vascor is prescribed for the long-term management of chronic conditions such as essential high blood pressure and chronic heart failure. Treatment for these conditions generally requires consistent, daily dosing over an extended period.


Q: Is Vascor considered a 'water pill' or a diuretic?

Vascor belongs to the ACE inhibitor pharmacological class. While its mechanism of action can cause an increase in the excretion of water and sodium from the body (known as natriuresis), it is not formally classified as a primary diuretic ('water pill').


Q: Does Vascor interact with supplements like potassium or magnesium?

Official warnings state that taking Vascor with potassium supplements or potassium-sparing diuretics increases the risk of elevated potassium levels (hyperkalemia). Information regarding interactions with other supplements should be discussed with a healthcare provider.


Q: Can Vascor cause changes in my blood sugar levels?

Official warnings indicate that the medicine should be used with caution in patients who have diabetes due to an increased risk of altered blood glucose levels. This caution reflects a need for close monitoring if this medicine is used in that population.


Q: Does Vascor (Imidapril) make people tired or cause fatigue?

In addition to more commonly reported effects, regulatory safety information lists fatigue and general weakness as possible adverse effects of the medicine.


Q: Are there any specific safety warnings for older patients taking Vascor?

Official guidance specifies that elderly patients (65+) are eligible for treatment but may be advised to start with a lower initial dose. This reflects a need for special consideration regarding dosage in this population.


Q: Can Vascor be used to protect the heart after a heart attack?

Research has examined the use of ACE inhibitors, as a pharmaceutical class, in patients with heart conditions such as reduced ejection fraction following a myocardial infarction. The medicine is studied for its use in patients with certain heart conditions to manage symptoms and support cardiac function.


Q: Is Vascor the same thing as Ramipril?

Vascor contains the active ingredient Imidapril, which is a distinct chemical entity from Ramipril. However, both medications belong to the same pharmacological class, which is ACE inhibitors, and are used to treat high blood pressure.


Q: Can Vascor cause changes in my sense of taste?

Regulatory documents list a possible adverse effect of taste disturbance, also known as dysgeusia. This is generally a less common effect, but it is officially documented as a potential adverse reaction.


Q: Is Vascor often used for patients with diabetic nephropathy?

The medication is described in official documentation as being used in some regions for the treatment of diabetic nephropathy. This is a specific type of kidney disease that can be related to diabetes.


Q: What are the signs of having too much potassium (hyperkalemia) due to Vascor?

Symptoms of elevated potassium levels (hyperkalemia) mentioned in safety literature can include signs such as muscle weakness and sensations of numbness or tingling in the limbs.


Q: Can Vascor be used in children?

Official regulatory documentation indicates that the medicine is not recommended for use in the pediatric population (typically below 18 years of age). This is because the safety and effectiveness have generally not been established for this age group.


Q: Does Vascor need to be stored in the refrigerator?

The official storage requirement is to keep the tablets protected from moisture and light at a temperature below 25°C. They should not be stored in the refrigerator or freezer.


Q: Is Vascor a controlled substance?

Imidapril is a type of medication used to treat high blood pressure (an ACE inhibitor). It is not classified as a controlled substance in the United States or regulated under similar narcotics control laws.


Q: Do I need to change my diet when starting Vascor?

Official regulatory documentation highlights the need to be aware of the intake of potassium-rich foods due to the potential for elevated potassium levels. It also warns that alcohol consumption may increase the pressure-lowering effect of the medication.

Advertisements

How should Vascor (Imidapril) be stored and disposed of?

How to Store and Dispose of Vascor (Imidapril)

Official regulatory labeling dictates specific conditions for the storage and disposal of Vascor (Imidapril) tablets to ensure product stability and safety.

Storage Requirements

Item Official Constraint
Temperature Store below 25°C. Do not refrigerate or freeze.
Protection Must be protected from moisture and light.
Container Store in the original package (or outer carton).
Child Safety Keep out of the sight and reach of children.

Disposal Instructions

Expired or unused Imidapril must be disposed of according to standard pharmaceutical guidelines. Regulatory documents state that the medicine must not be thrown away via wastewater or household waste. Individuals should consult a pharmacist to determine the appropriate method for discarding the product in compliance with local environmental regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Vascor (Imidapril) found in:

A-Z Index: